COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa.
COVID-19
Zambia
vaccine
vaccine acceptance
vaccine hesitancy
vaccine safety
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
31 12 2022
31 12 2022
Historique:
pubmed:
7
7
2021
medline:
16
3
2022
entrez:
6
7
2021
Statut:
ppublish
Résumé
With unprecedented speed, multiple vaccines against SARS-CoV-2 are available 1 year after the COVID-19 pandemic was first identified. As we push to achieve global control through these new vaccines, old challenges present themselves, including cold-chain storage, the logistics of mass vaccination, and vaccine hesitancy. Understanding how much hesitancy toward COVID-19 vaccines might occur and what factors may be driving these concerns can improve the ability of public health workers and communicators to maximize vaccine uptake. We nested a survey within a measles-rubella mass vaccination campaign in Zambia in November 2020 and asked about sentiments and beliefs toward COVID-19 and COVID-19 vaccines. Among parents bringing their children to receive a measles-rubella vaccine, we found high acceptability of COVID-19 vaccination of their children, but substantial uncertainty and hesitancy about receiving the vaccine themselves. COVID-19 vaccination hesitancy was correlated with beliefs around COVID-19 severity and risk, as well as vaccine safety and effectiveness.
Identifiants
pubmed: 34227914
doi: 10.1080/21645515.2021.1948784
pmc: PMC8920139
doi:
Substances chimiques
COVID-19 Vaccines
0
Measles Vaccine
0
Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-6Références
Vaccine. 2021 Mar 12;39(11):1556-1564
pubmed: 33618947
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
R Soc Open Sci. 2020 Sep 16;7(9):200742
pubmed: 33047037
Bull World Health Organ. 2018 Feb 01;96(2):86-93
pubmed: 29403111
Vaccine. 2017 Sep 5;35(37):4840-4850
pubmed: 28760616
Front Psychol. 2020 Sep 30;11:551004
pubmed: 33117223
Soc Sci Med. 2021 Mar;272:113688
pubmed: 33485215
Soc Sci Med. 2019 Nov;240:112552
pubmed: 31561111
Vaccine. 2018 Nov 29;36(50):7666-7673
pubmed: 30391054
MMWR Morb Mortal Wkly Rep. 2020 May 01;69(17):515-520
pubmed: 32352953
R Soc Open Sci. 2020 Oct 14;7(10):201199
pubmed: 33204475
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
Vaccine. 2020 Nov 10;38(48):7668-7673
pubmed: 33071002
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Health Promot J Austr. 2019 Apr;30(2):143-152
pubmed: 30091836